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SUMO-targeted ubiquitin ligase (STUbL) Slx5 
regulates proteolysis of centromeric histone H3 
variant Cse4 and prevents its mislocalization to 
euchromatin
ABSTRACT Centromeric histone H3, CENP-ACse4, is essential for faithful chromosome segre-
gation. Stringent regulation of cellular levels of CENP-ACse4 restricts its localization to centro-
meres. Mislocalization of CENP-ACse4 is associated with aneuploidy in yeast and flies and tu-
morigenesis in human cells; thus defining pathways that regulate CENP-A levels is critical for 
understanding how mislocalization of CENP-A contributes to aneuploidy in human cancers. 
Previous work in budding yeast shows that ubiquitination of overexpressed Cse4 by Psh1, an 
E3 ligase, partially contributes to proteolysis of Cse4. Here we provide the first evidence that 
Cse4 is sumoylated by E3 ligases Siz1 and Siz2 in vivo and in vitro. Ubiquitination of Cse4 by 
the small ubiquitin-related modifier (SUMO)-targeted ubiquitin ligase (STUbL) Slx5 plays a 
critical role in proteolysis of Cse4 and prevents mislocalization of Cse4 to euchromatin under 
normal physiological conditions. Accumulation of sumoylated Cse4 species and increased 
stability of Cse4 in slx5∆ strains suggest that sumoylation precedes ubiquitin-mediated pro-
teolysis of Cse4. Slx5-mediated Cse4 proteolysis is independent of Psh1, since slx5∆ psh1∆ 
strains exhibit higher levels of Cse4 stability and mislocalization than either slx5∆ or psh1∆ 
strains. Our results demonstrate a role for Slx5 in ubiquitin-mediated proteolysis of Cse4 to 
prevent its mislocalization and maintain genome stability.
INTRODUCTION
Centromeres are specialized chromosomal loci that are essential for 
faithful chromosome segregation. The kinetochore (centromeric 
DNA and associated proteins) provides an attachment site for 
microtubules for segregation of sister chromatids during mitosis. 
Despite the wide divergence of centromere DNA sequences, kinet-
ochore proteins such as centromeric histone H3 variant are evolu-
tionarily conserved from yeast to humans (Cse4 in Saccharomyces 
cerevisiae, Cnp1 in Schizosaccharomyces pombe, CID in Drosophila, 
and CENP-A in mammals) and are essential for chromosome segre-
gation (Kitagawa and Hieter, 2001; Smith, 2002; Biggins, 2013). The 
function of CENP-A is also evolutionarily conserved, as budding 
yeast Cse4 can rescue a depletion of mammalian CENP-A (Wieland 
et al., 2004).
Stringent regulation of CENP-A expression is essential for ge-
nome stability. Overexpression of CENP-A causes ectopic mislocal-
ization to chromosome arms and promotes aneuploidy in humans, 
flies, and yeast (Scott and Sullivan, 2014). Overexpression and 
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several proteins, including Mot1 and MATα 2 (Wang and Prelich, 
2009; Xie et al., 2010), nuclear Siz1 during mitosis (Westerbeck 
et al., 2014), and proteins involved in the DNA damage response 
and genome maintenance (Cook et al., 2009; Hickey et al., 2012; 
Garza and Pillus, 2013; Sriramachandran and Dohmen, 2014). Slx5, 
but not Slx8, has been shown to associate with centromeres, and 
slx5∆ and slx8∆ mutants show defects in chromosome segregation 
(van de Pasch et al., 2013). Depletion of the human homologue of 
Slx5/8, RNF4, also leads to chromosome segregation errors (van de 
Pasch et al., 2013), suggesting that the role of Slx5/8 is evolution-
arily conserved. The kinetochore substrates targeted and modified 
by Slx5/8 have not been identified, and therefore the role of STUbL 
proteins in chromosome segregation and genome stability is not 
well understood.
Here we provide evidence that Cse4 is sumoylated by SUMO E3 
ligases Siz1 and Siz2 in vivo and in vitro and that SUMO modification 
of Cse4 regulates its proteolysis. Slx5 plays a critical role in ubiqui-
tin-mediated proteolysis of Cse4 and prevents mislocalization of 
Cse4 under normal physiological conditions. Mislocalized Cse4 is 
highly stable and is not efficiently degraded in psh1∆ and slx5∆ 
strains. Our results show that Slx5 regulates ubiquitin-mediated pro-
teolysis of Cse4 to prevent its mislocalization in a Psh1-independent 
manner.
RESULTS
Cse4 is sumoylated in vitro and in vivo
Protein posttranslational modifications such as ubiquitination and 
sumoylation are important for regulating steady-state levels of cel-
lular proteins (Kerscher et al., 2006; Everett et al., 2013). Although 
canonical histones are sumoylated (Nathan et al., 2006), there is no 
evidence for sumoylation of Cse4. Optimization of the biochemical 
purification of Cse4 allowed us to detect sumoylation of Cse4 in 
vivo. We performed a pull down of octahistidine-hemagglutinin 
(8His-HA)–tagged Cse4 using nickel-nitrilotriacetic acid (Ni-NTA) 
agarose beads and detected SUMO-modified Cse4 by Western blot 
analysis with an anti-Smt3 antibody (Figure 1A). Protein levels of 
cse4 16KR, in which all lysine (K) residues are mutated to arginine 
(R), were greatly increased due to its stabilization, as reported previ-
ously (Collins et al., 2004). At least three high–molecular weight 
bands were observed after transient overexpression of 8His-HA–
Cse4 in wild-type cells (Figure 1A, long exposure, denoted by ar-
rows). In contrast, these SUMO-modified Cse4 species, which are 
visible on wild-type 8His-HA–Cse4, were not detected with vector 
alone or 8His-HA–cse4 16KR. These results show that Cse4 is 
sumoylated in vivo.
To identify the SUMO E3 ligase responsible for Cse4 sumoylation, 
we tested the role of two functionally redundant SUMO E3 ligases, 
Siz1 and Siz2, that are responsible for sumoylation of a majority of 
substrates (Johnson and Gupta, 2001; Johnson, 2004; Takahashi 
et al., 2001; Montpetit et al., 2006; Reindle et al., 2006), includ-
ing the kinetochore protein Ndc10 and histones H2B and H4 in 
S. cerevisiae (Montpetit et al., 2006; Nathan et al., 2006). In vitro 
sumoylation assays using purified Cse4 (Supplemental Figure S1) 
revealed that Siz1 serves as an E3 for Cse4 sumoylation (Figure 1B). 
We tested a siz1∆ siz2∆ mutant to determine the role of Siz1 and 
Siz2 in sumoylation of Cse4 in vivo (Figure 1C). We failed to detect 
SUMO-modified Cse4 species in the siz1∆ siz2∆ strain compared 
with the wild-type strain (Figure 1C, pull down). The lower levels of 
input Cse4 in the siz1∆ siz2∆ strain may be due to their slow growth 
and/or a defect in transcriptional induction from the GAL promoter 
(Figure 1C, input); however, SUMO-modified Cse4 species were not 
detected in the siz1∆ siz2∆ strain even upon a longer exposure 
mislocalization of CENP-A are observed in many cancers and con-
tribute to tumorigenesis in human cells (Tomonaga et al., 2003; 
Amato et al., 2009; Hu et al., 2010; Li et al., 2011; Wu et al., 2012; 
Lacoste et al., 2014; Athwal et al., 2015). In flies, mislocalization of 
CID causes formation of ectopic kinetochores and leads to mitotic 
delays, anaphase bridges, chromosome fragmentation, aneuploidy, 
and lethality (Heun et al., 2006). In fission yeast, overexpression of 
Cnp1 leads to indiscriminate deposition of Cnp1 at noncentromeric 
regions, resulting in growth defects and severe chromosome 
missegregation during mitosis and meiosis (Choi et al., 2012; 
Castillo et al., 2013; Gonzalez et al., 2014). In budding yeast, mislo-
calization of Cse4 to euchromatin leads to chromosome segrega-
tion defects, and the extent of Cse4 mislocalization directly corre-
lates with the level of chromosome loss (Au et al., 2008). Furthermore, 
various pathways involving kinetochore protein Spt4 (Crotti and 
Basrai, 2004), histone chaperones Cac1 and Hir1 (Sharp et al., 
2002; Lopes da Rosa et al., 2011), and chromatin remodeler Snf2 
(Gkikopoulos et al., 2011) act to prevent the mislocalization of Cse4.
Protein posttranslational modifications, such as ubiquitination 
(Kerscher et al., 2006), are important for regulating steady-state lev-
els and preventing mislocalization. For example, proteolysis of CID 
prevents its mislocalization to ectopic regions in flies (Heun et al., 
2006; Moreno-Moreno et al., 2011). Proteolysis of CENP-A has also 
been observed in senescent human cells or upon infection with her-
pes simplex virus 1 (Lomonte et al., 2001; Maehara et al., 2010). In 
fission yeast, the N-terminus of Cnp1 regulates ubiquitin-mediated 
proteolysis of Cnp1 and prevents its mislocalization to ectopic loci 
(Gonzalez et al., 2014). In budding yeast, ubiquitin-mediated prote-
olysis of Cse4 by E3 ubiquitin ligase Psh1 (Hewawasam et al., 2010; 
Ranjitkar et al., 2010) and proline isomerase Fpr3 (Ohkuni et al., 
2014) regulates cellular levels of Cse4. Both the N-terminus of Cse4 
and the centromere-targeting domain in the C-terminus of Cse4 
(which interacts with Psh1) are required for proteolysis of overex-
pressed Cse4 (Hewawasam et al., 2010; Ranjitkar et al., 2010; Au 
et al., 2013). Psh1-mediated proteolysis of Cse4 is also affected by 
the facilitates chromatin transcription/transactions (FACT) complex 
(Deyter and Biggins, 2014) and phosphorylation of Psh1 by casein 
kinase 2 (Hewawasam et al., 2014). Given that Cse4 is not com-
pletely stabilized in the psh1∆ mutant, we hypothesize that addi-
tional mechanisms regulate proteolysis of Cse4. Identification of 
cellular pathways for CENP-A proteolysis is critical for understand-
ing mechanisms that prevent mislocalization of CENP-A and aneu-
ploidy in human cancers.
In addition to ubiquitination, sumoylation is also a critical modi-
fier of chromatin proteins, such as histone H3 (Nathan et al., 2006). 
Sumoylation affects several biological processes, including tran-
scription, signal transduction, and genome integrity, by regulating 
protein–protein or protein–DNA interactions or by localization and 
stability of the interacting proteins (Ulrich, 2009; Gareau and Lima, 
2010; Everett et al., 2013; Flotho and Melchior, 2013; Jentsch and 
Psakhye, 2013). A recent study showed that the interaction of 
CDC48/p97 with sumoylated CENP-A activates rRNA genes in Ara-
bidopsis thaliana (Merai et al., 2014). However, these studies did not 
define the sumoylation enzymes or a functional role for sumoylated 
CENP-A in chromosome segregation. In budding yeast, the cova-
lent attachment of Smt3, a small ubiquitin-related modifier (SUMO), 
to target lysines requires the activity of E3 SUMO ligases such as 
Siz1 and Siz2 (Johnson and Gupta, 2001; Takahashi et al., 2001). 
SUMO-targeted ubiquitin ligases (STUbLs) link SUMO and ubiquitin 
modification pathways and facilitate proteolysis of the substrate. 
Slx5 and Slx8, two of at least four STUbLs proteins in S. cerevisiae, 
form a heterodimer to mediate SUMO-targeted degradation of 
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FIGURE 1: Cse4 is sumoylated by Siz1/2 in vitro and in vivo. (A) Cse4 is sumoylated in vivo. Wild-type strain (BY4741) 
transformed with vector (pYES2), pGAL-8His-HA-CSE4 (pMB1345), or pGAL-8His-HA-cse4 16KR (pMB1344) was grown 
in raffinose/galactose (2%) for 4 h to induce expression of Cse4. Sumoylation levels of Cse4 and nonmodified Cse4 were 
detected using Ni-NTA pull down, followed by Western blot analysis with anti-Smt3 and anti-HA (Cse4) antibodies, 
respectively. At least three high molecular weights of 8His-HA–Cse4 (arrows) were detected (Long exposure). Input 
samples were analyzed using anti-HA (Cse4) and anti-Tub2 antibodies. Asterisk shows nonspecific sumoylated proteins 
that bind to the beads. The mutations of lysine to arginine in 8His-HA–cse4 16KR slightly affect its mobility compared 
with wild-type 8His-HA-Cse4. (B) In vitro assay for Cse4 sumoylation. E1 (GST-Uba2/GST-Aos1), E2 (Ubc9), Smt3gg, and 
ATP were incubated with or without Siz1∆440. After the reaction, SUMO and SUMO-conjugated Cse4 were detected by 
Western blot analysis with anti-Smt3 and anti-Cse4 antibodies, respectively. (C) SUMO E3 ligases Siz1 and Siz2 
sumoylate Cse4 in vivo. Wild-type (BY4741) and siz1∆ siz2∆ (YMB7277) strains expressing pGAL-8His-HA-CSE4 
(pMB1345) were assayed as described in A. High–molecular weight species of 8His-HA–Cse4 and nonspecific 
sumoylated proteins are marked with arrows and an asterisk, respectively.
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species, suggesting that Slx5-mediated proteolysis is a downstream 
consequence of Cse4 sumoylation.
We next examined whether higher levels of sumoylated Cse4 
species accumulate in the slx5∆ strain under normal physiological 
conditions. Even though sumoylated Cse4 species were detected in 
wild-type cells when Cse4 is overexpressed (Figure 1A), we failed to 
detect sumoylated Cse4 species in the wild-type strain when Cse4 
is expressed from its own promoter (Figure 2F). The failure to detect 
sumoylated Cse4 species may be due to low Cse4 expression and/
or ongoing proteolysis of sumoylated Cse4. In contrast, higher lev-
els of sumoylated Cse4 species were clearly observed in the slx5∆ 
mutant (Figure 2F, arrows). A defect in STUbL activity may in part 
contribute to accumulation of polysumoylated (high–molecular 
weight) Cse4 species in the slx5∆ strain. Sumoylated Cse4 does not 
accumulate in strains deleted for PSH1, an E3-ubiquitin ligase tar-
geting Cse4, or in SIZ1/SIZ2-deleted strains. These results indicate 
that lack of STUbL activity in slx5∆ strains contributes to the accumu-
lation of sumoylated Cse4 species under normal physiological 
conditions.
Slx5 regulates ubiquitin-mediated proteolysis of Cse4 
in a Psh1-independent manner
Previous studies showed that Psh1 interacts with Cse4 and CSE4 
overexpression causes growth inhibition in a psh1∆ strain 
(Hewawasam et al., 2010; Ranjitkar et al., 2010). Similar to the 
growth defect observed for psh1∆ strains, slx5∆ and siz1∆ siz2∆ 
strains also showed growth inhibition with GAL-CSE4 on galactose 
medium (Supplemental Figure S3). Given that Slx5 and Psh1 are 
E3 ligases that ubiquitinate Cse4 and that deletion of SLX5 results 
in accumulation of sumoylated Cse4 species, we examined 
whether Slx5-mediated proteolysis of Cse4 is dependent on Psh1. 
We constructed psh1∆ slx5∆ strains using standard yeast mating 
and sporulation. The psh1∆ slx5∆ strains do not exhibit growth 
defects at 30°C but exhibit a slow-growth phenotype at low (22, 
25°C) and high (37°C) temperatures compared with each single 
mutant (Supplemental Figure S4A). The psh1∆ slx5∆ strains also 
exhibit sensitivity to growth on benomyl (microtubule-depolymer-
izing agent)–containing plates. Furthermore, psh1∆ slx5∆ strains 
exhibit defects in segregation of a reporter chromosome in a col-
ony color assay to measure chromosome transmission fidelity 
(Supplemental Figure S4B).
We next analyzed the stability of Cse4 after transient overexpres-
sion of HA-Cse4 in wild-type, psh1∆, slx5∆, and psh1∆ slx5∆ strains 
(Figure 3A). As expected, deletion of PSH1 or SLX5 moderately 
stabilized HA-Cse4 protein levels. In contrast, the double-deletion 
mutant psh1∆ slx5∆ showed a dramatic increase in HA-Cse4 protein 
stability. The half-life of HA-Cse4 in psh1∆ slx5∆ (t1/2 = 138.6 min) is 
twice that of psh1∆ (t1/2 = 77.0 min) or slx5∆ (t1/2 = 69.3 min) strains 
(Figure 3B). We next analyzed Cse4 stability in strains expressing 
HA-Cse4 from its own promoter. Protein stability assays showed that 
Cse4 is rapidly degraded in wild-type cells (t1/2 = 34.7 min), mod-
estly stable in psh1∆ (t1/2 = 46.2 min) and slx5∆ (t1/2 = 53.3 min) sin-
gle mutants, and highly stable in psh1∆ slx5∆ strain (t1/2 = 77.0 min; 
Figure 3, C and D). We conclude that Slx5 regulates ubiquitin-medi-
ated proteolysis of Cse4 independently of Psh1.
Slx5 prevents mislocalization of Cse4 in a Psh1-independent 
manner
We investigated the physiological consequence of defects in STUbL 
activity by analyzing Cse4 localization in strains expressing Cse4 
from its endogenous promoter. Subcellular fractionation and 
chromosome spreads were used to examine whether Cse4 was 
(Figure 1C, long exposure). Our results show that SUMO E3 ligases 
Siz1 and Siz2 sumoylate Cse4 in vivo.
The STUbL Slx5 regulates ubiquitin-mediated proteolysis 
of Cse4
Previous studies showed that STUbLs link SUMO and ubiquitin 
modification pathways to facilitate proteolysis of cellular substrates 
(Garza and Pillus, 2013; Sriramachandran and Dohmen, 2014). Slx5, 
one of four STUbL proteins (Slx5, Slx8, Uls1, Rad18) in S. cerevisiae, 
forms a complex with Siz1 (Westerbeck et al., 2014), and slx5∆ 
strains exhibit chromosome segregation defects (van de Pasch 
et al., 2013). Hence we investigated the role of Slx5 in Cse4 prote-
olysis. To investigate whether Slx5 interacts with Cse4 in vivo, we 
performed a glutathione S-transferase (GST) pull-down assay using a 
strain expressing GST-tagged Slx5 and HA-tagged Cse4. Slx5-GST 
was affinity purified on glutathione sepharose, and copurifying HA-
Cse4 was detected by Western blot analysis with anti-HA antibody 
(Figure 2A). Our results show that GST-Slx5 interacts with HA-Cse4 
in vivo.
To determine whether Slx5 ubiquitinates Cse4 in vivo, we per-
formed an affinity pull-down assay using agarose with tandem ubiq-
uitin-binding entities (Ub+) from a strain expressing HA-tagged Cse4 
(Figure 2B). Ubiquitinated Cse4 was detected as a laddering pattern 
in wild-type cells expressing HA-Cse4 but was absent in strains with 
vector alone. Faster-migrating Cse4 species (Figure 2B, asterisk) 
similar in size to those in the input lane were observed from both 
wild-type and slx5∆ strains. These species were also observed in 
experiments with wild-type Cse4 and cse4 16KR mutant, in which all 
lysines are mutated to arginines (Au et al., 2013; Hewawasam et al., 
2014). Because cse4 16KR cannot be ubiquitinated, this faster-mi-
grating species represents unmodified Cse4, which likely interacts 
with ubiquitinated proteins such as canonical histones. The ladder-
ing pattern of higher–molecular weight forms of Cse4 was greatly 
reduced in an slx5∆ strain (Figure 2B). Quantification of ubiquiti-
nated Cse4 showed a fivefold reduction in high–molecular weight 
forms of Cse4 when normalized to input Cse4 in the slx5∆ strain 
(Figure 2C). We next investigated whether defects in Cse4 ubiquiti-
nation result in increased protein stability in vivo. Overexpressed 
HA-tagged Cse4 was transiently induced from a GAL promoter by 
the addition of galactose, and cells were shifted to glucose medium 
containing cycloheximide (CHX) to inhibit translation. Western blot 
analysis with protein extracts from different time points was used to 
measure levels of Cse4 after CHX treatment (Figure 2D). HA-Cse4 
was rapidly degraded in the wild-type strain (t1/2 = 39.0 min) yet was 
stabilized in the slx5∆ strain (t1/2 = 73.2 min). Consistent with this 
observation, we detected a similar stabilization of Cse4 in the siz1∆ 
siz2∆ strain (t1/2 = 74.8 vs. 35.8 min in wild type; Supplemental 
Figure S2). Thus we conclude that Slx5 is required for ubiquitination 
and proteolysis of Cse4 in vivo.
Because slx5∆ strains show defects in Cse4 ubiquitination and 
increased stability of Cse4, we examined whether sumoylated Cse4 
accumulates in these strains. We first constructed a strain expressing 
His-Flag-tagged Smt3 (HF-Smt3) and Myc-tagged Cse4. HF-Smt3 
was purified from cell extracts using Ni-NTA agarose beads, and the 
level of sumoylated proteins and sumoylated Cse4 was determined 
using anti-Flag (Smt3) and anti-Myc (Cse4) antibodies, respectively. 
When Myc-Cse4 was transiently overexpressed, SUMO-modified 
Cse4 species were barely detectable in the wild-type strain (Figure 
2E, α-Myc). In contrast, the slx5∆ strain showed substantial levels of 
sumoylated Cse4, especially high–molecular weight, SUMO- modi-
fied Cse4 (Figure 2E, α-Myc). Therefore reduced STUbL activity in 
slx5∆ strain contributes to the accumulation of sumoylated Cse4 
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FIGURE 2: The STUbL Slx5 interacts with Cse4 and regulates ubiquitin-mediated proteolysis of Cse4. (A) Slx5 associates 
with Cse4. Expression of pGAL-3HA-CSE4 (pMB1515) and/or pGAL-GST-SLX5 (BOK629) in ubc4∆ ubc6∆ (YOK2501) was 
induced by the addition of galactose (2%) for 6 h. Glutathione–Sepharose beads were used for GST-Slx5 pull down, and 
the eluate was analyzed by Western blot analysis with anti-HA (Cse4) and anti-GST (Slx5) antibodies. (B) Slx5 regulates 
Cse4 ubiquitination. Wild-type (BY4741) and slx5∆ (YMB9035) strains expressing pGAL-3HA-CSE4 (pMB1597) were 
grown in raffinose/galactose (2%) for 2 h. Agarose-TUBE1 was used for pull down with tandem ubiquitin-binding entities. 
Ubiquitination levels of Cse4 were detected by Western blot analysis with anti-HA antibody, and input samples were 
analyzed using anti-HA (Cse4) and anti-Tub2 antibodies. Wild-type (BY4741) strain transformed with vector (pMB433) 
was used as a negative control. Asterisk shows nonmodified Cse4. (C) Relative ubiquitination of Cse4 with average 
deviation of two biological repeats. Cse4 was normalized using input Cse4 levels. (D) Increased stability of Cse4 in slx5∆ 
strain. Cse4 expression from pGAL-6His-3HA-CSE4 (pMB1458) in wild-type (BY4741) and slx5∆ (YMB9035) strains was 
induced by the addition of galactose (2%) for 2 h. Glucose (2%) containing CHX (10 μg/ml) was added, and cells were 
collected at the indicated time points. Blots were probed with anti-HA (Cse4) or anti-Tub2 (loading control) antibody. 
Cse4 protein half-life (t1/2) represents the mean of two biological repeats with average deviation. (E) Deletion of SLX5 
shows an accumulation of sumoylated Cse4 species. Wild-type (YMB7278) and slx5∆ (YMB7875) strains expressing 
pGAL-13Myc-CSE4 (pSB816) were grown in raffinose/galactose (2%) for 4 h. His-Flag–tagged Smt3 (HF-Smt3) was 
pulled down by Ni-NTA agarose beads. Cellular levels of sumoylated proteins and sumoylated Cse4 were detected by 
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is restricted to centromeres (Figure 4A). In contrast, Cse4 was en-
riched in chromatin in psh1∆ and slx5∆ strains, and this enrichment 
was further enhanced in psh1∆ slx5∆ strains. Similar results were ob-
served for chromatin enrichment of Cse4 transiently overexpressed 
from a GAL promoter in psh1∆ and slx5∆ strains, with maximum 
enrichment in the psh1∆ slx5∆ strain (Supplemental Figure S5). 
These results suggest that Slx5 regulates localization of Cse4 inde-
pendently of Psh1.
mislocalized in the slx5∆ strain. These approaches were previously 
used to show that defects in ubiquitin-mediated proteolysis of Cse4 
in a psh1∆ strain led to the enrichment of Cse4 in chromatin and 
mislocalization to euchromatin when Cse4 was overexpressed 
(Hewawasam et al., 2010; Ranjitkar et al., 2010; Deyter and Biggins, 
2014). Subcellular fractionation of whole-cell lysates was performed 
with psh1∆, slx5∆, and psh1∆ slx5∆ strains. Cse4 was barely detect-
able in the chromatin fraction in a wild-type strain, as its localization 
Western blot analysis with anti-Flag (Smt3) and anti-Myc (Cse4) antibodies, respectively. Two different exposures are 
shown. (F) Deletion of SLX5, but not PSH1, shows an accumulation of sumoylated Cse4 expressed from its own 
promoter. Protein extracts were prepared from cells grown to logarithmic phase in YPD. Sumoylation levels of Cse4 and 
nonmodified Cse4 were detected using Ni-NTA pull down, followed by Western blot analysis with anti-Smt3 and anti-HA 
(Cse4) antibodies, respectively. Input samples were analyzed using anti-HA (Cse4) and anti-Tub2 antibodies. At least 
three high molecular weights of 6His-3HA–Cse4 (arrows) were detected in the slx5∆ strain. Asterisk shows nonspecific 
sumoylated proteins that bind to the beads. Isogenic yeast strains used are wild type (YMB7290), slx5∆ (YMB7588), 
psh1∆ (YMB7393), and siz1∆ siz2∆ (YMB7611) and untagged strains (BY4742, YMB9034, YMB9035, YMB7277).
FIGURE 3: Slx5 regulates Cse4 proteolysis in a Psh1-independent manner. (A) Cse4 expressed from galactose-inducible 
promoter is highly stable in psh1∆ slx5∆ strain. Wild-type (BY4741), psh1∆ (YMB9034), slx5∆ (YMB9035), and psh1∆ 
slx5∆ (YMB9040) strains expressing pGAL-6His-3HA-CSE4 (pMB1458) were assayed as described in Figure 2D. 
(B) Kinetics of turnover from A. Cse4 protein half-life (t1/2) is indicated. Error bars in wild type and psh1∆ slx5∆ represent 
average deviation of two replicates. (C) Cse4 expressed from its own promoter is moderately stabilized in psh1∆ and 
slx5∆ strains and highly stable in psh1∆ slx5∆ strain. Protein extracts were prepared from cells grown to logarithmic 
phase in YPD, treated with CHX (20 μg/ml) for various time points, and analyzed by Western blot analysis with anti-HA 
(Cse4) or anti-Tub2 (loading control) antibody. Isogenic yeast strains used are wild type (YMB7290), psh1∆ (YMB7393), 
slx5∆ (YMB7588), and psh1∆ slx5∆ (YMB7607). (D) Kinetics of turnover from C. Cse4 protein half-life (t1/2) is indicated, 
and error bars in wild-type and psh1∆ slx5∆ strains represent average deviation of two replicates.
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We next used chromosome spreads, a technique that removes 
soluble material to visualize localization of chromatin-bound Cse4 in 
wild-type, psh1∆, slx5∆, and psh1∆ slx5∆ strains expressing Cse4 
from own promoter (Figure 4B). In wild-type cells, Cse4 foci were 
restricted to one or two dots, which correspond to kinetochore clus-
ters. In contrast, diffused or multiple foci of Cse4 that overlapped 
with the 4′,6-diamidino-2-phenylindole (DAPI)–stained nucleus were 
observed in psh1∆ and slx5∆ strains, and this was further exacer-
bated in psh1∆ slx5∆ cells (Figure 4, B and C). On the basis of these 
results, we conclude that Slx5 and Psh1 prevent mislocalization of 
Cse4 under normal physiological conditions and that Slx5 regulates 
localization of Cse4 in a Psh1-independent manner.
Fluorescence recovery after photobleaching analysis 
shows that mislocalized Cse4 is highly stable in psh1∆ 
and slx5∆ strains
To determine whether the euchromatic pool of mislocalized Cse4 
observed in chromosome spreads of slx5∆ and psh1∆ strains is sta-
bly incorporated, we performed fluorescence recovery after photo-
bleaching (FRAP) in both mutants. In wild-type strains, Cse4-GFP 
signal is restricted to the cluster of 16 kinetochores proximal to the 
spindle pole body, and Cse4 incorporated into kinetochores does 
not recover after photobleaching (Pearson et al., 2004). In addition 
to the kinetochore signal (foci), the nuclei of slx5∆ and psh1∆ strains 
show a diffuse fluorescence emanating from noncentromeric re-
gions (haze), consistent with the increased levels of Cse4 in chro-
matin fractions (Figure 4A) and mislocalization to euchromatin 
(Figure 4B). Similar to wild-type cells, the centromere Cse4-GFP foci 
in both slx5∆ and psh1∆ cells did not exhibit recovery after photo-
bleaching (Figure 5, A and B). We next examined FRAP of the Cse4-
GFP haze in slx5∆ and psh1∆ strains. For psh1∆ strains, we imaged 
Cse4-GFP haze every 30 s postbleach (Figure 5, B and D); however, 
because the Cse4-GFP haze was dimmer in slx5∆, we used only two 
Z-series (immediately postbleach and 5 min postbleach) after laser 
bleaching to minimize photobleaching from imaging (Figure 5, A and 
C). Similar to the centromere Cse4-GFP foci, the Cse4-GFP haze did 
not exhibit recovery after photobleaching in either slx5∆ or psh1∆ 
cells (Figure 5, C and D). We conclude that the ectopically localized 
Cse4 present in slx5∆ and psh1∆ cells, once deposited, is stable.
DISCUSSION
In this study, we showed that sumoylation and ubiquitination of 
Cse4 regulate its proteolysis and prevent its mislocalization. We pro-
vide the first evidence for sumoylation of Cse4, by SUMO E3 ligases 
Siz1 and Siz2 in vivo and in vitro, and define a role for Slx5 in ubiq-
uitin-mediated proteolysis of Cse4. Slx5-mediated proteolysis of 
Cse4 is independent of Psh1, and Cse4 is mislocalized to euchroma-
tin in both psh1∆ and slx5∆ strains under normal physiological con-
ditions. Consistent with these results, Cse4 is highly enriched in the 
chromatin fraction and stably incorporated into euchromatin in 
psh1∆ and slx5∆ strains. Taken together, our results support a role 
for Slx5 in ubiquitination of sumoylated Cse4 to regulate its prote-
olysis and localization.
Several lines of evidence support the role of Slx5 in proteolysis of 
Cse4. Overexpression of CSE4 results in growth inhibition in slx5∆ 
and siz1∆ siz2∆ strains, similar to psh1∆ strain (Hewawasam et al., 
2010; Ranjitkar et al., 2010; Au et al., 2013). Second, defects in Cse4 
ubiquitination observed in slx5∆ strains correlate with an increased 
half-life of Cse4 in these strains. Higher stability of Cse4 is also ob-
served in an slx8∆ strain (unpublished data), suggesting that the het-
erodimeric Slx5/8 STUbL complex is important for Cse4 proteolysis. 
Third, deletion of SLX5 leads to accumulation of higher–molecular 
FIGURE 4: Slx5 prevents mislocalization of Cse4 to euchromatin. 
(A) Cse4 expressed from its own promoter is increased in chromatin 
fraction in psh1∆, slx5∆, and psh1∆ slx5∆ strains. Whole-cell extracts 
(WCEs) prepared from equal numbers of logarithmically growing cells 
in YPD were fractionated into soluble and chromatin fraction and 
assayed by Western blot analysis. Tub2 and histone H3 were used as 
markers for soluble and chromatin fractions, respectively. Two blots 
shown for Cse4 are indicated (L, long exposure; S, short exposure). 
(B, C) Cse4 expressed from its own promoter is mislocalized in psh1∆, 
slx5∆, and psh1∆ slx5∆ strains. Chromosome spreads were done by 
logarithmically growing cells in YPD. DAPI (blue) and α-HA (red) 
staining were used to visualize DNA and Cse4 localization, 
respectively. In wild-type strains, Cse4 is predominantly localized to 
one or two kinetochore clusters. In mutant strains, mislocalization of 
Cse4 is observed as multiple foci or diffused localization throughout 
the nucleus. The graph quantifies the number of cells exhibiting Cse4 
mislocalization, and error bars are average deviation of two 
independent experiments. The number of cells used is indicated (n). 
Isogenic yeast strains used are wild type (YMB7290), psh1∆ 
(YMB7393), slx5∆ (YMB7588), and psh1∆ slx5∆ (YMB7607).
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these phenotypes are further exacerbated 
in the slx5∆ psh1∆ double mutant. Previous 
studies examined Cse4 turnover only in the 
context of the kinetochore, where it is stably 
incorporated into chromatin (Pearson et al., 
2004). Although the signal is low, the in-
creased levels of noncentromeric Cse4 
present in slx5∆ and psh1∆ strains (the 
“haze”) enable analysis by FRAP. The appar-
ent stability of mislocalized Cse4 observed 
by FRAP suggests that ectopically localized 
Cse4 is stably incorporated in the euchro-
matin; however, it is also possible that the 
ectopic Cse4-containing nucleosomes are 
dynamic, in equilibrium with (non–fluores-
cently tagged) H3 in the nucleus (Verdaas-
donk et al., 2012). The latter explanation 
would require that the exchange mecha-
nism uses a different Cse4/H3 pool than 
that under which the Cse4 was initially 
misincorporated.
We propose a model (Figure 6) in which 
sumoylation and ubiquitination regulate 
Cse4 proteolysis to prevent its stable incor-
poration into euchromatin. At least two in-
dependent pathways regulate Cse4 prote-
olysis. One is dependent on the interaction 
of Psh1 with Cse4, which is potentiated by 
the nucleosome-destabilizing activity of the 
FACT complex. This suggests that Psh1 is 
primarily responsible for removing nucleo-
somal Cse4 at noncentromeric chromatin, 
even though the interaction of Psh1 and 
soluble Cse4 is also reduced in the absence 
of FACT (Deyter and Biggins, 2014). The 
second pathway, identified here, requires 
sumoylation of Cse4 by Siz1/Siz2 and subse-
quent ubiquitination of Cse4 by Slx5 to 
regulate cellular levels of Cse4 and prevent its mislocalization to 
euchromatin. Although we do not yet know whether the Siz1/2-Slx5 
pathway acts on soluble Cse4 or chromatin-bound Cse4, together 
the two pathways act to regulate cellular levels of Cse4 and prevent 
its mislocalization to euchromatin. Given that mislocalization of 
Cse4 leads to chromosome segregation defects, it is not surprising 
that cells use multiple ubiquitination pathways for proteolysis of 
high levels of Cse4.
Unlike Psh1, Slx5 and Slx8 are evolutionarily conserved, and de-
pletion of the human STUbL orthologue, RNF4, results in defects in 
chromosome segregation (van de Pasch et al., 2013). Similar to Slx5, 
it is possible that RNF4 also regulates the localization of CENP-A and 
that defects in this pathway lead to chromosome missegregation. 
Previous studies showed that mislocalization of centromeric histone 
H3 variants Cse4, Cnp1, and CID contribute to chromosome segrega-
tion defects in flies and budding/fission yeast (Heun et al., 2006; Au 
et al., 2008; Gonzalez et al., 2014). Thus we propose that the mislo-
calization of CENP-A contributes to chromosome segregation de-
fects in slx5∆ and RNF4-depleted cells. These studies are important, 
as we do not fully understand how overexpression and mislocalization 
of CENP-A observed in many cancers contribute to tumorigenesis. 
Our studies on the role of STUbLs in ubiquitin-mediated proteolysis 
of Cse4 provide mechanistic insights into pathways that prevent mis-
localization of CENP-A and aneuploidy in human cancers.
weight species of sumoylated Cse4. Similar results for higher levels 
of sumoylated Mot1, a regulator of TATA-binding protein and de-
fects in proteolysis, were observed when SLX5 and/or SLX8 are de-
leted (Wang and Prelich, 2009). Accumulation of sumoylated Cse4 
species and increased stability of Cse4 in the slx5∆ strain suggest 
that sumoylation precedes ubiquitin-mediated proteolysis of Cse4. 
These phenotypes are not limited to cases in which Cse4 is overex-
pressed (e.g., using the GAL promoter); higher levels of sumoylated 
Cse4 and increased stability of Cse4 are also observed under physi-
ological conditions when Cse4 is expressed from its own promoter.
 The increased stability of Cse4 in the psh1∆ slx5∆ double mu-
tant compared with either the slx5∆ or psh1∆ single mutant shows 
that Slx5-mediated proteolysis of Cse4 is independent of Psh1 un-
der normal physiological conditions. The residual proteolysis of 
Cse4 observed in psh1∆ slx5∆ strains suggests that additional path-
ways/regulators that have yet to be identified also mediate Cse4 
proteolysis. This is perhaps not surprising, given that degradation of 
excess of histone H3 is also regulated by at least five E3 ubiquitin 
ligases (Singh et al., 2012). In addition, non–ubiquitin-mediated 
pathways partially contribute to Cse4 proteolysis because mutant 
cse4 16KR, in which all lysines are changed to arginine, is still de-
graded (Collins et al., 2004; Au et al., 2013).
Endogenously expressed Cse4 is enriched in chromatin fractions 
and mislocalized to euchromatin in slx5∆ and psh1∆ strains, and 
FIGURE 5: Cse4 is stable in euchromatin in slx5∆ and psh1∆ strains. Representative images of 
slx5∆ (A) and psh1∆ (B) cells containing Cse4-GFP before (Pre), immediately after (0 min), and 
5 min after photobleaching. Foci correspond to Cse4-GFP enrichment at centromeres. Haze 
corresponds to Cse4-GFP at euchromatin. Arrows indicate bleached area. Images were 
compiled using maximum projection. Scale bar, 1 μm. Plots of average normalized intensity of 
the bleached area over time for slx5∆ (C) and psh1∆ (D). Integrated intensity was background 
subtracted and corrected for photobleaching. Error bars show SD. Bleaching was set at t = 30 s. 
For slx5∆, nine cells were used each for foci and haze, and for psh1∆, eight cells each for foci 
and haze. Isogenic yeast strains used are slx5∆ (YMB9429) and psh1∆ (YMB9430).
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GST pull-down assay
The ubc4∆ ubc6∆ (YOK 2501) strain was 
transformed with pGAL-GST-SLX5 (BOK 
629, Open Biosystems Yeast GST Collec-
tion YSC4515202484078), pGAL-3HA-CSE4 
(pMB 1515), or both pGAL-GST-SLX5 
and pGAL-3HA-CSE4. Transformants were 
grown in appropriate selective medium with 
proline as nitrogen source and 2% sucrose 
to logarithmic phase, and then 2% galac-
tose and 0.003% SDS were added to the 
cultures and incubation continued for an-
other 6 h. MG132, 75 μM, was added ½ h 
before harvesting of the cells. We assayed 
200 OD units of yeast cells as described pre-
viously (Westerbeck et al., 2014). Whole-cell 
extracts (2 OD) and pull down (20 OD) were 
analyzed by Western blot analysis.
Subcellular fractionation and 
chromosome spreads
Subcellular fractionation to assay chromatin 
enrichment of Cse4 was performed as de-
scribed previously (Au et al., 2008). Cells 
were grown to logarithmic phase of growth in 1% yeast extract, 2% 
bactopeptone, and 2% glucose (YPD) at 25°C. Chromosome 
spreads were performed as described previously (Collins et al., 
2004; Crotti and Basrai, 2004) with some modifications. 16B12 
mouse anti-HA antibody (MMS-101P; Covance, Emeryville, CA) was 
used as primary antibody at 1:2500 dilution. Cy3-conjugated goat 
anti-mouse (115165003; Jackson ImmunoResearch Laboratories, 
West Grove, PA) was used as secondary antibody at 1:5000 dilution. 
Cells were visualized by DAPI staining (1 μg/ml in phosphate-buff-
ered saline) mounted in antifade mountant (P36935; Molecular 
Probes, Eugene, OR). Cells were observed under an Axioskop 2 
(Zeiss) fluorescence microscope equipped with a Plan-Apochromat 
100× (Zeiss, Thornwood, NY) oil immersion lens. Image acquisition 
and processing were performed with the IP Lab version 3.9.9 r3 
software (Scanalytics, Fairfax, VA).
Antibodies
Antibodies for experiments were as follows: rabbit polyclonal anti-
Cse4 (Strunnikov laboratory), anti-Tub2 antibodies (Basrai labora-
tory), anti-HA (12CA5; Roche, Indianapolis, IN), anti-HA (ab9110; 
Abcam, Cambridge, MA), anti-myc (A-14; Santa Cruz Biotechnol-
ogy, Dallas, TX), anti-GST (ab6613; Abcam), anti-Smt3 (y-84; Santa 
Cruz Biotechnology), and anti-H3 (ab1791; Abcam). Anti-Cse4 was 
used at a dilution of 1:1000, anti-HA was used at a dilution from 
1:1000 to 1:10,000, anti-Tub2 and anti-Smt3 were used at 1:3000, 
and anti-GST and anti-H3 were used at 1:5000. 
FRAP
Strains YMB9430 (Cse4-GFP, psh1∆) and YMB9429 (Cse4-GFP, slx5∆) 
were grown in YPD to mid logarithmic growth phase before imaging. 
Both YMB9430 and YMB9429 were grown at 24° C, but YMB9429 
was shifted to 37°C 6 h before imaging. Cells were imaged using a 
Nikon Eclipse Ti wide-field inverted microscope with a 100×/1.49 
numerical aperture Apo total internal reflection fluorescence objec-
tive (Nikon, Melville, NY) and Andor Clara charge-coupled device 
camera (Andor, South Windsor, CT) using Nikon NIS Elements imag-
ing software. Photobleaching was performed with a Sapphire 488-50 
CDRH laser (Coherent, Santa Clara, CA). A seven-step Z-series with 
MATERIALS AND METHODS
Yeast strains and plasmids
Supplemental Tables S1 and S2 describe the genotype of yeast 
strains and plasmids used for this study, respectively.
Sumoylation assay in vivo and in vitro
In vivo sumoylation was assayed in crude yeast extracts using Ni-
NTA agarose beads to pull down His-HA–tagged Cse4 or His-
Flag–tagged Smt3 (HF-Smt3) under denaturing condition, as de-
scribed previously (Ohkuni et al., 2015). In vitro sumoylation 
assays were carried out as described previously (Takahashi et al., 
2003). Briefly, the components of the conjugation reaction—
Smt3gg, GST-Uba2, GST-Aos1, Ubc9, and Siz1-∆440 proteins—
were expressed and purified from Escherichia coli and then used 
in the reaction mixture containing Cse4 as a substrate. Cse4 was 
produced in E. coli and purified by Sephacryl-S200 chromatogra-
phy as described (Luger et al., 1997). Substrate (Cse4), E1 (GST-
Uba2, GST-Aos1), E2 (Ubc9), and SUMO (Smt3gg) were incu-
bated in a total volume 20 μl for 60 min in the presence of 10 mM 
ATP, 50 mM Tris-HCl (pH 8.0), 5 mM MgCl2, and 2 mM dithio-
threitol at 37˚C. The reaction was stopped by adding 2× Laemmli 
buffer.
Protein stability and ubiquitin pull-down assays
Protein stability assay was performed as described previously 
(Ohkuni et al., 2014) with some modifications. Cells were grown 
to logarithmic phase of growth in a 2% raffinose synthetic com-
plete medium at 25°C. Galactose was added to the medium to a 
final concentration of 2% to induce Cse4 expression from the 
GAL promoter for 2 h at 25°C. CHX and glucose were then 
added to final concentrations of 10 μg/ml and 2%, respectively. 
Samples were taken at the indicated time points, and levels of 
Cse4 were quantified by Western blot analysis. Protein levels at 
each time point were quantified using Gene Tools software (ver-
sion 3.8.8.0) from SynGene (Frederick, MD). Ubiquitin pull-down 
assays were performed by inducing HA-tagged Cse4 from a GAL 
promoter by the addition of galactose (2%) for 2 h, as described 
previously (Au et al., 2013).
FIGURE 6: Model for how Slx5 regulates proteolysis of Cse4 and prevents its mislocalization to 
euchromatin. Restricting the localization of Cse4 to centromeric DNA is essential for faithful 
chromosome segregation. At least two independent pathways prevent the stable incorporation 
of Cse4 into euchromatin. One of these pathways is dependent on the interaction of Psh1 with 
Cse4. The second pathway requires sumoylation of Cse4 by Siz1/Siz2 and ubiquitination of 
sumoylated Cse4 by Slx5. The two pathways may a) regulate soluble pools of Cse4 to prevent 
its mislocalization and/or b) facilitate proteolysis of chromatin-bound Cse4.
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200-nm step size with 600-ms exposure time was taken before a 300-
ms exposure from the laser. Immediately after the laser exposure, a 
5-min time lapse with 30-s intervals with the same settings as the first 
Z-series was initiated. The Z-series was compiled into single images 
using maximum projection, and the integrated intensity of the 
bleached area was measured using MetaMorph 7.7 imaging soft-
ware (Molecular Devices, Sunnyvale, CA). The integrated intensity of 
the bleached area had the integrated intensity of the cell back-
ground subtracted at each time point, and photobleaching was cor-
rected for by determining the average bleaching rate of a nearby 
Cse4-GFP signal and adding back the average signal loss per Z-se-
ries. Photobleaching and background subtraction was performed 
using Excel (Microsoft, Redmond, WA).
Chromosome transmission fidelity
The chromosome transmission fidelity assay was performed as de-
scribed previously (Spencer et al., 1990; Ohkuni et al., 2008). Strains 
were plated on synthetic medium with limiting adenine and incu-
bated at 25°C for 4 d. Loss of the reporter chromosome results in red 
sectors in an otherwise white colony. Colonies that are at least half red 
indicate loss of the reporter chromosome in the first cell division.
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SUPPLEMENTAL INFORMATION 
Supplemental Figure S1. Purified Cse4 used for in vitro reaction. Coomassie blue 
staining of purified Cse4 for in vitro reaction is shown. 
 
Supplemental Figure S2. Deletion of SIZ1 and SIZ2 stabilizes Cse4 protein level in vivo. 
Cse4 expression from pGAL-6His-3HA-CSE4 (pMB1458) in wild-type (BY4741) and 
siz1∆ siz2∆ (YMB7277) strains was induced by the addition of galactose (2%) for 2 hrs. 
Glucose (2%) containing cycloheximide (CHX, 10 µg/ml) was added and cells were 
collected at the indicated time points. Blots were probed with anti-HA (Cse4) or anti-
Tub2 (loading control) antibody. Cse4 protein half life (t1/2) represents the mean of two 
biological repeats with average deviation. 
 
Supplemental Figure S3. Synthetic dosage lethality of GAL-CSE4 in psh1∆, slx5∆, or 
siz1∆ siz2∆ mutants. Wild-type (BY4741), psh1∆ (YMB9034), slx5∆ (YMB9035), and 
siz1∆ siz2∆ (YMB7277) strains were transformed with either vector (pMB433) or pGAL-
6His-3HA-CSE4 (pMB1458). Yeast cells were spotted in 5-fold dilutions on glucose 
(2%)- or galactose (2%)- containing synthetic medium selective for vector or GAL-CSE4. 
The plates were incubated at 25°C for 4 days and photographed.  
 
Supplemental Figure S4. (A) psh1∆ slx5∆ strains exhibit temperature and benomyl 
sensitivities. Cells were spotted in 5-fold dilutions on YPD and YPD supplemented with 
benomyl. The plates were incubated at indicated temperatures for 2 days and 
photographed. Isogenic yeast strains used are wild-type (BY4741), psh1∆ (YMB9034), 
slx5∆ (YMB9035), psh1∆::natR slx5∆::kanMX (YMB9037 and 9038), and 
psh1∆::kanMX slx5∆::natR (YMB9039 and 9040). (B) psh1∆ slx5∆ strains exhibit 
defects in chromosome transmission fidelity. Chromosome loss was determined by 
counting the number of colonies that show loss of the reporter chromosome in the first 
division and exhibit a half sector phenotype. Statistical significance was determined by 
chi-square test. NS, not significant. Isogenic yeast strains used are wild-type (YMB9378 
and 9379), psh1∆ (YMB9425 and 9426), slx5∆ (YMB9375 and 9376), and psh1∆ slx5∆ 
(YMB9427 and 9428). 
 
Supplemental Figure S5. Cse4 is highly enriched in the chromatin fraction in psh1∆ 
slx5∆ cells. Wild-type (BY4741), psh1∆ (YMB9034), slx5∆ (YMB9035), and psh1∆ 
slx5∆ (YMB9040) strains transformed with pGAL-3HA-CSE4 (pMB1597) were used for 
subcellular fractionation. Cse4 expression was induced by the addition of galactose (2%) 
for 4 hrs. Whole cell extracts (WCE) were fractionated into soluble and chromatin 
fractions. Cse4 levels in each fraction were monitored by western blot analysis with anti-
HA antibody. Tub2 and histone H3 were used as markers for soluble and chromatin 
fractions, respectively. 
 
  
Supplemental Table S1. S. cerevisiae stains used in this study 
Strains  Parent  Genotype      Reference 
BY4741    MATa his3∆1 leu2∆0 met15∆0 ura3∆0   Open Biosystems 
BY4742    MATα  his3∆1 leu2∆0 lys2∆0 ura3∆0   Open Biosystems 
YMB7277 BY4741/BY4742 MATa siz1∆::kanMX6 siz2∆::kanMX6   This study 
YMB7278 BY4741/BY4742 MATa HF-SMT3::LEU2    (Ohkuni et al., 2015) 
YMB7290 BY4741/BY4742 MATα  cse4∆::kanMX6 [pRS316-6His-3HA-CSE4] This study 
YMB7393 BY4741/BY4742 MATα  cse4∆::kanMX6 psh1∆::kanMX6  This study 
    [pRS316-6His-3HA-CSE4] 
YMB7588 BY4741/BY4742 MATα  cse4∆::kanMX6 slx5∆::kanMX6  This study 
    [pRS316-6His-3HA-CSE4] 
YMB7607 BY4741/BY4742 MATa cse4∆::kanMX6 psh1∆::kanMX6 slx5∆::kanMX6 This study 
    [pRS316-6His-3HA-CSE4] 
YMB7611 BY4741/BY4742 MATα  cse4∆::kanMX6 siz1∆::kanMX6 siz2∆::kanMX6 This study 
[pRS316-6His-3HA-CSE4] 
YMB7875 BY4741/BY4742 MATa HF-SMT3::LEU2 slx5∆::kanMX6  This study 
YMB9034 BY4741  MATa psh1∆::kanMX6    Open Biosystems 
YMB9035 BY4741  MATa slx5∆::kanMX6    Open Biosystems 
YMB9037 BY4741/BY4742 MATa psh1∆::NatR slx5∆::kanMX6   This study 
YMB9038 BY4741/BY4742 MATa psh1∆::NatR slx5∆::kanMX6   This study 
YMB9039 BY4741/BY4742 MATa psh1∆::kanMX6 slx5∆::NatR   This study 
YMB9040 BY4741/BY4742 MATa psh1∆::kanMX6 slx5∆::NatR   This study 
YMB8898   MATa ura3-52 trp1∆63 leu2∆1 lys2-801 his3∆200 473A This study 
    Spc29RFP:Hb CSE4∆::6His-GFP-CSE4:mx4NAT 
YMB9429 YMB8898 MATa ura3-52 trp1∆63 leu2∆1 lys2-801 his3∆200 473A This study 
    Spc29RFP:Hb CSE4∆::6His-GFP-CSE4:mx4NAT 
    slx5∆::kanMX6 
YMB9430 YMB8898 MATa ura3-52 trp1∆63 leu2∆1 lys2-801 his3∆200 473A This study 
    Spc29RFP:Hb CSE4∆::6His-GFP-CSE4:mx4NAT 
    psh1∆::kanMX6 
YOK2501 MHY3765 MATα  ura3-52 lys2-801 trp1-∆63 his3-∆200        (Westerbeck et al., 2014) 
leu2-∆1 ubc4::HIS3 ubc6::TRP1 alpha2::kanMX6  
YMB9378   MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 F. Holstege 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
YMB9379   MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 F. Holstege 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
YMB9375   MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 F. Holstege 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
    slx5∆::His3MX6 
YMB9376   MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 F. Holstege 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
    slx5∆::His3MX6 
YMB9425 YMB9378 MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 This study 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
    psh1∆::kanMX6 
YMB9426 YMB9379 MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 This study 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
    psh1∆::kanMX6 
YMB9427 YMB9375 MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 This study 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
    psh1∆::kanMX6 slx5∆::His3MX6 
YMB9428 YMB9376 MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 This study 
    ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11 
    psh1∆::kanMX6 slx5∆::His3MX6 
 
 
Supplemental Table S2. Plasmids used in this study. 
Plasmid  Relevant characteristics     Reference 
pYES2  Vector (pGAL, 2µ, URA3)     (Boeckmann et al., 2013) 
pMB430 Vector (p425-pGAL1, 2µ, LEU2)    (Mumberg et al., 1994) 
pMB433 Vector (p426-pGAL1, 2µ, URA3)    (Mumberg et al., 1994) 
pSB816  pRS426-pGAL-13Myc-CSE4 (2µ, URA3)   (Collins et al., 2004) 
pRB199  pRS316-6His-3HA-CSE4 (CEN, URA3)   (Boeckmann et al., 2013)  
pMB1344 pYES2-pGAL-8His-HA-cse4 16KR (2µ, URA3)  This study 
pMB1345 pYES2-pGAL-8His-HA-CSE4 (2µ, URA3)   This study   
pMB1458 pMB433-pGAL-6His-3HA-CSE4 (2µ, URA3)  (Au et al., 2013) 
pMB1515 pMB430- pGAL-3HA-CSE4 (2µ, LEU2)   This study 
pMB1597 pMB433-pGAL-3HA-CSE4 (2µ, URA3)   This study 
BOK629 pGAL1/10-GST-SLX5     Open Biosystems 
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